(Q48432702)

11 February 2018

title

Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats (English)

1 reference

11 February 2018

0 references

1 reference

Adrie W Bruijnzeel

1

1 reference

11 February 2018

George Zislis

series ordinal

2

1 reference

11 February 2018

Carrie Wilson

series ordinal

3

1 reference

11 February 2018

Mark S Gold

series ordinal

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

30 August 2006

1 reference

11 February 2018

published in

Neuropsychopharmacology

1 reference

11 February 2018

volume

32

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

955-963

1 reference

11 February 2018

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Nornicotine is self-administered intravenously by rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Psychostimulant withdrawal as an inducing condition in animal models of depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Severe deficit in brain reward function associated with fentanyl withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Nicotine maintains robust self-administration in rats on a limited-access schedule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Nicotine self-administration in rats on a progressive ratio schedule of reinforcement.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Dramatic decreases in brain reward function during nicotine withdrawal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Corticotropin-releasing factor, norepinephrine, and stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Opponent Process Model and Psychostimulant Addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Plasticity of reward neurocircuitry and the 'dark side' of drug addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Corticotropin‐Releasing Factor Stimulates Catecholamine Release in Hypothalamus and Prefrontal Cortex in Freely Moving Rats as Assessed by Microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Rodent model of nicotine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Decreased brain reward produced by ethanol withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Modulation by corticotropin-releasing factor of monoamine metabolism in the lateral hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

The scientific case that nicotine is addictive.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Blockade of nicotine self-administration with nicotinic antagonists in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301192

1 reference

11 February 2018

1 reference

11 February 2018